TOKYO STOCKS END MIXED OVER APPROVAL OF ALZHEIMER’S DRUG

Highlights –

• Tokyo stocks end mixed over approval of Alzheimer’s drug.
• The 225-issue Nikkei Stock Average ended down 55.68 points, or 0.19 percent.
• Topix index of all First Section issues on the TSE finished 1.80 points, or 0.09 percent.
• Stocks declined in pulp and paper and nonferrous metal issues.

The U.S. approval of an Alzheimer's drug dev....